Drug intelligence / Profile preview

4-bromo-3-(carboxymethoxy)-5-(4-hydroxyphenyl)thiophene-2-carboxylic acid

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a synthetic small molecule belonging to the class of thiophene carboxylic acids, characterized by a thiophene ring substituted with bromine, carboxymethoxy, and hydroxyphenyl groups. It is listed as an experimental molecule in drug databases and has not been approved for any therapeutic use. There is no available information on its mechanism of action, biological targets, or clinical development. Its primary relevance appears to be as a research chemical or tool compound rather than as an active pharmaceutical ingredient[1][2][3][8].

Other names: 4-bromo-3-(carboxymethoxy)-5-(4-hydroxyphenyl)thiophene-2-carboxylic acid5-(4-hydroxyphenyl)thiophene-2-carboxylic acid

Beyond the preview

Go deeper on 4-bromo-3-(carboxymethoxy)-5-(4-hydroxyphenyl)thiophene-2-carboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-bromo-3-(carboxymethoxy)-5-(4-hydroxyphenyl)thiophene-2-carboxylic acid.

Explore the full profile